2005
DOI: 10.1097/01.mlg.0000160085.98289.e8
|View full text |Cite
|
Sign up to set email alerts
|

Alcohol Withdrawal Prophylaxis in Patients Undergoing Surgical Treatment of Head and Neck Squamous Cell Carcinoma

Abstract: Alcohol withdrawal is associated with a significantly greater incidence of postoperative complications and duration of hospitalization. Benzodiazepine prophylaxis does not prevent postoperative alcohol withdrawal symptoms in all patients at risk. Alternate methods of prophylaxis should be explored.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
21
0

Year Published

2006
2006
2017
2017

Publication Types

Select...
5
2

Relationship

1
6

Authors

Journals

citations
Cited by 21 publications
(21 citation statements)
references
References 10 publications
0
21
0
Order By: Relevance
“…We added a variable for altered mental status, which included alcohol withdrawal, given its association with postoperative complications. 15,16 We also added donor site function to assess short-term disability from free tissue transfer.…”
Section: Resultsmentioning
confidence: 99%
“…We added a variable for altered mental status, which included alcohol withdrawal, given its association with postoperative complications. 15,16 We also added donor site function to assess short-term disability from free tissue transfer.…”
Section: Resultsmentioning
confidence: 99%
“…In surgical patients, alcohol abuse has been shown to be a significant risk factor for increased postoperative morbidity and mortality 1, 6, 7. Patients who abuse alcohol have significantly more postoperative complications and longer in‐hospital lengths of stay compared to patients without a history of alcohol abuse,1, 8–12 due at least in part to increased rates of infection, bleeding, and cardiopulmonary dysfunction 1, 8, 11, 12…”
Section: Introductionmentioning
confidence: 99%
“…The average increase in overall hospital stay was statistically significant for those patients experiencing withdrawal symptoms and DTs. The AWD group had a length of stay 6.1 days longer and the group experiencing DTs 9.6 days longer (Neyman et al, 2005). A delay in identification and treatment could be life threatening for the patient experiencing AWD.…”
Section: Background/literaturementioning
confidence: 97%